Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now?

Key Takeaways ISRG's Q4 prelims showed 18% procedure growth, roughly $2.87B revenues and 532 da Vinci system placements.ISRG's I&A revenues rose 17% on higher procedures, though pricing pressure remained in China and ASC settings.ISRG saw strong da Vinci 5 demand lift system ASPs, while tariffs and margins weighed on earnings outlook.Intuitive Surgical, Inc. (ISRG) is set to report fourth-quarter 2025 earnings on Feb. 22. The Zacks Consensus Estimate for sales and earnings is pegged at $2.87 billion and $2. ...